Clinical validation of the 2021 European Society of Cardiology guidelines on preexisting right bundle branch block in patients undergoing transcatheter aortic valve implantation
In this large cohort of patients with preexisting RBBB undergoing TAVI with contemporary prosthesis and implantation techniques, the ESC criteria-PR prolongation, QRS axis change, and transient HAVB-correctly identified 4 of 5 patients in whom HAVB developed during 30-day follow-up.
Authors
- Gregor Leibundgut (ORCID: https://orcid.org/0000-0002-0122-5397)
- Philipp Krisai (ORCID: https://orcid.org/0000-0002-4367-2363)
- Andrea Papa (ORCID: https://orcid.org/0000-0001-6770-0173)
- Teodor Serban (ORCID: https://orcid.org/0000-0002-2377-2893)
- Felix Mahfoud (ORCID: https://orcid.org/0000-0002-4425-549X)
- Michael Kühne (ORCID: https://orcid.org/0000-0002-2937-3711)
- Thomas Nestelberger (ORCID: https://orcid.org/0000-0003-2173-5738)
- Beat Schaer (ORCID: https://orcid.org/0000-0003-1768-1968)
- Patrick Badertscher (ORCID: https://orcid.org/0000-0001-9751-0557)
- Sven Knecht (ORCID: https://orcid.org/0000-0001-7122-021X)
- Christian Sticherling (ORCID: https://orcid.org/0000-0001-8428-7050)
- Marc Salis
- Christoph Kaiser (ORCID: https://orcid.org/0000-0002-9463-0892)
Institutions
- University Hospital of Basel (CH)
- Hospital Base (CL)
Publication Details
- Journal
- Heart Rhythm
- Published
- 2024-11-22
- DOI
- https://doi.org/10.1016/j.hrthm.2024.11.030
- Citations
- 4
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- National Science Foundation
- Pfizer
- Edwards Lifesciences
- Foundation for Cardiovascular Research
- Universität Basel
- Boston Scientific Corporation
- Freiwillige Akademische Gesellschaft
- European Commission
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Schweizerische Herzstiftung
- Medizinische Abteilung der Margarete und Walter Lichtenstein-Stiftung
- Biosense Webster
- Daiichi Sankyo Europe